The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Proteinuria as a predictive factor in metastatic colorectal cancer patients treated with bevacizumab.
Mukremin Uysal
No relevant relationships to disclose
Hakan Sat Bozcuk
No relevant relationships to disclose
Sema Sezgin Goksu
No relevant relationships to disclose
Ali Murat Tatli
No relevant relationships to disclose
Deniz Arslan
No relevant relationships to disclose
Seyda Gunduz
No relevant relationships to disclose
Hasan Senol Coskun
No relevant relationships to disclose
Mustafa Ozdogan
No relevant relationships to disclose
Burhan Savas
No relevant relationships to disclose